Testing devices

News • Achieving and maintaining high service quality

QA in histopathology laboratories from pre- to post-analytic phase

Testing from histopathology laboratories is considered the gold standard for many diseases. To avoid errors that can significantly impact patient outcomes, an expert details on quality assurance (QA).

News • Quicker, cheaper and less painful test

Blood crystals to reveal early signs of prostate cancer

A new method of analysing the crystals in dehydrated blood could lead to a quicker, cheaper and less painful technique to diagnose, early detect, and monitor prostate cancer.

News • Promising research on oral rinse-based test

Wash, rinse – detect head and neck cancer?

Can a mouthwash-based test help predict head and neck cancer recurrence? A new study suggests it might.

News • Promising diagnostic tool

Alzheimer's: New test to detect side effect risk from drugs

A novel test aims to predict whether Alzheimer’s patients are genetically predisposed to side effects from anti-amyloid drugs, a promising new class of Alzheimer’s therapeutics.

News • HPV oncoprotein quantification

Urine test improves cervical cancer early detection

A new test shows promise in making cervical cancer screening more accessible and less invasive by detecting oncoproteins of the human papillomavirus (HPV) in urine samples.

News • Biomarkers enhance early detection

Parkinson's: blood test predicts disease up to seven years before symptoms

A novel blood test shows promise to predict Parkinson's disease in risk patients up to seven years before the typical motor symptoms appear.

News • Millifluidic nanogenerator

Blood-powered lab-on-a-chip to enhance disease monitoring

Researchers are proposing a new device that uses blood to generate electricity and measure its conductivity, opening doors to medical care in any location.

News • Integration of microanalysis chips

Establishing microfluidic control technology for blood testing devices

A research group established a microfluidic control technology that can be applied to small blood testing devices and consequently developed a novel integrated immunoassay device.

News • Urine-based diagnostics

New prostate cancer test to help avoid unnecessary biopsies

US researchers have developed and validated a new urine-based test for prostate cancer, which was shown to meaningfully reduce unnecessary prostate biopsies while providing highly accurate detection.

Article • Proof-of-concept study

First test for the early detection of head and neck cancer being developed

Most head and neck tumours are discovered in late due in part to the fact that there is no established method for early detection. To close this gap, a team at oncgnostics, a biotechnology company based in Jena, Germany, is participating in a study which aims to develop an early detection test.

News • Saliva test device

Breast cancer screening: Biosensor could offer alternative to diagnostic imaging

A newly-developed biosensor could be an alterative to MRI and mammography for breast cancer screening. The handheld device uses saliva on test strips to determine whether cancer is present.

Article • QC at AACC 2023

New risk-based quality control assessment for clinical labs

Juggling the cost of quality control (QC) resources versus the risk of testing error is a balancing act no clinical laboratory manager enjoys. It is an inexact process, itself prone to error, which can impact the operations of hospital labs and independent clinical testing companies. In the current resource-constrained healthcare environment, there is pressure to improve the cost effectiveness of…

News • Sexual health pilot project

Vending machines offer convenient STI testing

Vending machines dispensing self-test kits for sexually transmitted infections (STIs) have proven to be an effective and widely accepted means of reaching individuals who rarely or never get tested.

Meet Mako: the latest in X-ray QA testing

RTI presents its latest advancement in X-ray Quality Assurance and testing. Centered around efficiency, Mako provides the ultimate no-fuss experience, simple setup in all X-ray applications, and fully wireless capability.

Article • Addressing an unmet need

MCED: a simple test for widespread early detection of cancer

Academic labs and biotech firms pioneer multi-cancer early detection with emerging technologies. Screening for multiple cancers with a simple blood or urinary draw could be a game-changer. Two research teams in particular have advanced the field.

News • Noninvasive fetal screening

Blood test to identify genetic diseases in unborn babies

A research team from Denmark has developed an innovative screening test. With a blood sample from the expectant mother, they can scrutinize all the genes in the fetus.

News • Based on image-based flow cytometry

Rapid test to predict severe Covid-19 infections

Researchers have developed a method for assessing the number and structure of aggregated blood platelets (or thrombocytes) that can potentially help quantify the risk of a severe Covid-19 infection. As a result, they have identified a predictive biomarker for the seriousness of a Covid-19 infection. This will allow physicians to adjust treatment at an early stage. The researchers used a method…

News • Using AI nanopores

New rapid testing method for Covid-19

Researchers from Osaka University present a novel technique to detect different coronavirus variants quickly, including fast-spreading strains present in human saliva.

News • Preparing for the next pandemic

New rapid electronic diagnostic test for infectious diseases

A new molecular test for bacteria and viruses, including Sars-CoV-2, has been developed at the University of Surrey, as they warn that the world needs to be prepared for the next pandemic.

News • Spirometry distribution

The ‘silent scandal’ of missing lung tests across England

A new survey by The BMJ reveals shortages of vital diagnostic tests for respiratory conditions, such as COPD and asthma, across some of the most deprived areas of England.

Article • Cancer patients at risk

Blood test detects risk of neurotoxicity from CAR T-cell therapy

Chimeric antigen receptor (CAR) T-cell therapy is an immunotherapy treatment that re-engineers a patient’s own T-cells to help them attack malignant tumour cells. It has been very effective in the treatment of blood cancers, including certain types of leukaemia and lymphoma. However, two serious side effects are common as a result of the treatment: cytokine release syndrome (CRS) and immune…

News • MCED for 50+ cancer types

Multi-cancer blood test shows real promise

A trial of a new blood test for more than 50 types of cancer correctly revealed two out of every three cancers in more than 5,000 people who had visited their GP with suspected symptoms.

News • Pre-eclampsia

Detecting high-risk pregnancy with heart attack test

About 5% of all women develop pre-eclampsia during pregnancy, which in severe cases can become life-threatening for mother and child. Using commercially available troponin tests, high-risk patients could be identified much earlier and more accurately than before.

News • Molecular test for bacteria response

New method rapidly reveals antibiotic resistance

Researchers at Karolinska Institutet have developed a molecular method able to detect whether or not bacteria respond to antibiotics within minutes.

News • Perilous PSA policy

Prostate cancer ‘test by request’ drives overdiagnosis, argue experts

Experts argue that shared decision policies between patients and their doctors have led to high rates of PSA testing and clear medical harm, with minimal benefit and inequity.

122 show more articles